CC
KLRS

Centiva Capital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Centiva Capital’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,996
Closed -$99.7K – 2085
2024
Q2 		$99.7K Buy
+5,996
New +$99.7K ﹤0.01% 1385